FARMINGDALE, N.Y., March 28, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”) today announced its intention to voluntarily delist its common stock from The New York ...

New York Attorney General Letitia James announced Tuesday that Enzo Biochem (NYSE:ENZ) agreed to pay $4.5M and improve its ...

Enzo Biochem Inc. (NYSE:ENZ), a medical laboratory services provider with a market capitalization of $36.6 million, has ...

Enzo Biochem (ENZ) announced its intention to voluntarily delist its common stock from The NYSE and to have its common stock quoted on the ...

Equities research analysts at StockNews.com started coverage on shares of Enzo Biochem (NYSE:ENZ – Get Free Report) in a note issued to investors on Monday. The brokerage set a “hold” rating on the ...

Virtu Financial LLC purchased a new stake in shares of Enzo Biochem, Inc. (NYSE:ENZ – Free Report) during the 4th quarter, Holdings Channel.com reports. The fund purchased 48,341 shares of the medical ...

Proteins are the molecular building blocks and engines of the cell, and are involved in practically all life processes. Researchers at the Max Planck Institute of Biochemistry investigate the ...

FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $1.5 million in its fiscal second quarter. The Farmingdale, New York-based company said it had a ...

View all information regarding the medicines that are manufactured by Biochem Pharmaceutical Industries Ltd. including its generic drug name, trade name, how to use, the price, and its composition.

Regulations, 2015, board of directors at their meeting held on April 1, 2025, considered and approved the following matters as mentioned below: 1. Resignation of Ms. Silky Gupta as a Company Secretary ...

Regulations, 2015 and Company''s code of conduct for regulating, monitoring and reporting of trading by Insiders, the Trading Window for dealing in the equity shares of the Company by Designated ...